| rhEPO-b group (n = 19) | Placebo group (n =20) | RR (CI) p |
---|---|---|---|
Primary non-function | 0 | 0 | Â |
Delayed graft function n (%) | 10 (53%) | 11 (55%) | RR = 1.0 (0.5-1.6) p = 0.93 |
Slow graft function n (%) | 6 (32%) | 5 (25%) | RR = 1.1 (0.5-1.9) p = 0.73 |
Days to first dialysis* | 1 (1-3) | 1 (1-3) | Â |
Number of dialysis episodes* | 3 (1-17) | 4 (1-19) | Â |
Days to last dialysis* | 7 (1-41) | 8 (1-35) | Â |